William Schieterman

Shares of OXiGENE Inc (NASDAQ: OXGN), a nano-cap biopharmaceutical company that focuses on the treatment of cancer, spiked higher by 13 percent on Wednesday after the company announced that the U.S. Food and Drug Administration granted a Fast Track designation for one of its drugs. Oxigene...